Yes, patients taking tamoxifen can safely use an IUD, particularly a copper IUD without concerns, and a levonorgestrel IUD (LNG-IUS) after discussion with their oncologist.
Patients with breast cancer taking tamoxifen may consider a levonorgestrel-releasing intrauterine system 52 mg after consultation with their oncologist 1. The evidence shows no association between LNG-IUS use and breast cancer recurrence in tamoxifen-treated women 1.
Type of IUD Matters
Copper IUD (Cu-IUD)
- No hormonal concerns - Can be used without restriction in tamoxifen patients
- No systemic hormonal effects that could theoretically interfere with breast cancer treatment
- Provides highly effective contraception (as effective as permanent methods) 1
Levonorgestrel IUD (LNG-IUS/Mirena)
- Safe regarding breast cancer recurrence - Level I evidence shows no association with breast cancer recurrence 1
- Provides endometrial protection - Significantly reduces benign endometrial pathology (polyps, hyperplasia) that tamoxifen can cause 1, 2, 3
- The LNG-IUS prevents endometrial polyps with a Peto odds ratio of 0.14 (95% CI: 0.03-0.61) 2
- Protection only lasts while the device is in place - polyps can develop after removal 3
Key Clinical Considerations
Contraceptive efficacy: Both IUD types are as effective as permanent sterilization 1, making them excellent options for women who need reliable contraception during tamoxifen therapy.
Tamoxifen's contraceptive warning: The FDA label explicitly states that tamoxifen stops hormonal birth control methods (pills, patches, injections, rings, implants) from working, but specifically recommends "plain IUDs" as appropriate non-hormonal contraception 4. This directly supports IUD use in this population.
Endometrial benefits with LNG-IUS: Tamoxifen increases risk of endometrial polyps, hyperplasia, and cancer 4. The LNG-IUS provides local endometrial suppression that counteracts these proliferative effects 2, 3. Women with baseline endometrial thickness have higher polyp risk, making LNG-IUS particularly beneficial 3.
Bleeding patterns: The CDC guidelines note that tamoxifen (a SERM) can be used to treat bleeding irregularities in LNG-IUS users [5-5], demonstrating recognized compatibility between these medications.
Practical Algorithm for Decision-Making
Any woman on tamoxifen needing contraception: Offer IUD as first-line option
Choose IUD type based on:
- Copper IUD if: Patient prefers completely hormone-free option, has no menstrual concerns
- LNG-IUS if: Patient has heavy menstrual bleeding, dysmenorrhea, or documented endometrial changes from tamoxifen 1
For LNG-IUS: Discuss with oncologist (not because of safety concerns, but for coordinated care and documentation)
Counsel on: Expected bleeding changes (more irregular bleeding first 6 months with LNG-IUS, then improvement) 2
Important Caveats
- The evidence for LNG-IUS preventing endometrial cancer (versus benign polyps) in tamoxifen users is insufficient - studies weren't powered for this outcome 2
- LNG-IUS must remain in place for continued endometrial protection - benefits cease after removal 3
- Standard IUD insertion precautions apply (pregnancy exclusion, STI screening if high-risk) 1
- No routine antibiotic prophylaxis needed for insertion 1
The 2024 CDC contraception guidelines and 2016 Canadian guidelines both support IUD use in this population, with the Canadian guidelines specifically stating LNG-IUS use with tamoxifen shows no association with breast cancer recurrence (Level I evidence) 1.